Medifast Inc (MED) stock
MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3056% below fair value
$12.19−0.35 (-2.79%)
Close on Nov 17, 2026Market cap $136.32MP/E –Yield 0.00%
Medifast cash
Cash and short-term investments held at the end of each period.
Medifast's cash was $172.24M at Sep 30, 2026. For fiscal 2025 it was $166.35M, up 0.4% from the year before. Over ten years it grew 9.5% a year on average. The highest annual figure on record is $174.48M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $166.35M | +0.4% |
| FY2024 | Dec 31, 2024 | $165.62M | +11.0% |
| FY2023 | Dec 31, 2023 | $149.16M | +70.1% |
| FY2022 | Dec 31, 2022 | $87.69M | -19.9% |
| FY2021 | Dec 31, 2021 | $109.46M | -37.3% |
| FY2020 | Dec 31, 2020 | $174.48M | +88.3% |
| FY2019 | Dec 31, 2019 | $92.68M | -8.3% |
| FY2018 | Dec 31, 2018 | $101.03M | +2.2% |
| FY2017 | Dec 31, 2017 | $98.83M | +28.6% |
| FY2016 | Dec 31, 2016 | $76.85M | +14.5% |
| FY2015 | Dec 31, 2015 | $67.11M | +27.5% |
| FY2014 | Dec 31, 2014 | $52.64M | -22.4% |
| FY2013 | Dec 31, 2013 | $67.80M | +13.0% |
| FY2012 | Dec 31, 2012 | $59.99M | +77.5% |
| FY2011 | Dec 31, 2011 | $33.80M | -1.8% |
| FY2010 | Dec 31, 2010 | $34.44M | +224.7% |
| FY2009 | Dec 31, 2009 | $10.60M | +989.8% |
| FY2008 | Dec 31, 2008 | $973.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $172.24M | -0.3% |
| Q2 FY2026 | Jun 30, 2026 | $169.23M | +4.5% |
| Q1 FY2026 | Mar 31, 2026 | $168.44M | +0.8% |
| Q4 FY2025 | Dec 31, 2025 | $166.35M | +0.4% |
| Q3 FY2025 | Sep 30, 2025 | $172.81M | +0.1% |
| Q2 FY2025 | Jun 30, 2025 | $161.91M | -1.7% |
| Q1 FY2025 | Mar 31, 2025 | $167.14M | +9.0% |
| Q4 FY2024 | Dec 31, 2024 | $165.62M | +11.0% |
| Q3 FY2024 | Sep 30, 2024 | $172.65M | +9.6% |
| Q2 FY2024 | Jun 30, 2024 | $164.72M | +11.7% |
| Q1 FY2024 | Mar 31, 2024 | $153.34M | +23.9% |
| Q4 FY2023 | Dec 31, 2023 | $149.16M | +70.1% |
| Q3 FY2023 | Sep 30, 2023 | $157.47M | +125.9% |
| Q2 FY2023 | Jun 30, 2023 | $147.41M | +141.4% |
| Q1 FY2023 | Mar 31, 2023 | $123.75M | +1.4% |
| Q4 FY2022 | Dec 31, 2022 | $87.69M | -19.9% |
| Q3 FY2022 | Sep 30, 2022 | $69.71M | -56.4% |
| Q2 FY2022 | Jun 30, 2022 | $61.07M | -69.1% |
| Q1 FY2022 | Mar 31, 2022 | $122.06M | -42.7% |
| Q4 FY2021 | Dec 31, 2021 | $109.46M | -37.3% |
| Q3 FY2021 | Sep 30, 2021 | $159.90M | -5.9% |
| Q2 FY2021 | Jun 30, 2021 | $197.43M | +35.8% |
| Q1 FY2021 | Mar 31, 2021 | $212.91M | +102.3% |
| Q4 FY2020 | Dec 31, 2020 | $174.48M | +88.3% |
| Q3 FY2020 | Sep 30, 2020 | $169.92M | +75.3% |
| Q2 FY2020 | Jun 30, 2020 | $145.39M | +28.1% |
| Q1 FY2020 | Mar 31, 2020 | $105.26M | -12.6% |
| Q4 FY2019 | Dec 31, 2019 | $92.68M | -8.3% |
| Q3 FY2019 | Sep 30, 2019 | $96.91M | -6.1% |
| Q2 FY2019 | Jun 30, 2019 | $113.52M | +9.9% |
| Q1 FY2019 | Mar 31, 2019 | $120.43M | +10.2% |
| Q4 FY2018 | Dec 31, 2018 | $101.03M | +2.2% |
| Q3 FY2018 | Sep 30, 2018 | $103.22M | +7.8% |
| Q2 FY2018 | Jun 30, 2018 | $103.32M | +16.7% |
| Q1 FY2018 | Mar 31, 2018 | $109.24M | +38.4% |
| Q4 FY2017 | Dec 31, 2017 | $98.83M | +28.6% |
| Q3 FY2017 | Sep 30, 2017 | $95.73M | – |
| Q2 FY2017 | Jun 30, 2017 | $88.55M | – |
| Q1 FY2017 | Mar 31, 2017 | $78.96M | – |
| Q4 FY2016 | Dec 31, 2016 | $76.85M | – |
See a number that looks wrong?